The National Myelodysplastic Syndromes (MDS) Study

Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02775383
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.
Intervention
Therapeutic
Condition
Myelodysplastic Syndromes (MDS)
Investigators
Mikkael Sekeres, MD, MS, Amy DeZern, MD, MHS

See list of participating sites